UK regulator says some evidence AstraZeneca clots occur more in women than men
Britain’s medicine regulator on Thursday said there was some evidence that uncommon blood clots linked to AstraZeneca’s (AZN.L) COVID-19 vaccine occurred more in women than in men, adding that the difference in incidence was small.
Read More
Canada’s ex-finance minister breached ethics rules in charity dealings 
Judge axes employee wage claims, keeps others in Wawa data breach case